Literature DB >> 28700760

PURLs: Which combined OC to prescribe with CV safety in mind?

Yee Lam1, Catherine Coe1, Anne Mounsey1.   

Abstract

With various formulations available, which combined OC should you recommend to minimize not only the risk of PE, but also the risk of stroke and MI?

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28700760      PMCID： PMC5517134     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  11 in total

Review 1.  French health insurance databases: What interest for medical research?

Authors:  G Moulis; M Lapeyre-Mestre; A Palmaro; G Pugnet; J-L Montastruc; L Sailler
Journal:  Rev Med Interne       Date:  2014-12-26       Impact factor: 0.728

2.  French national health insurance information system and the permanent beneficiaries sample.

Authors:  P Tuppin; L de Roquefeuil; A Weill; P Ricordeau; Y Merlière
Journal:  Rev Epidemiol Sante Publique       Date:  2010-07-03       Impact factor: 1.019

3.  Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.

Authors:  M Akerlund; A Røde; J Westergaard
Journal:  Br J Obstet Gynaecol       Date:  1993-09

4.  Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; C R Thompson; J G Kennedy; I R Hambleton
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

5.  Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.

Authors:  John D Seeger; Jeanne Loughlin; P Mona Eng; C Robin Clifford; Jennifer Cutone; Alexander M Walker
Journal:  Obstet Gynecol       Date:  2007-09       Impact factor: 7.661

Review 6.  Smoking and risk of venous thromboembolism: a systematic review.

Authors:  Ge Zhang; Xin Xu; Wei Su; Qiuping Xu
Journal:  Southeast Asian J Trop Med Public Health       Date:  2014-05       Impact factor: 0.267

7.  Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Authors:  Øjvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Finn Egil Skjeldestad; Ellen Løkkegaard
Journal:  BMJ       Date:  2011-10-25

8.  Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.

Authors:  Alain Weill; Marie Dalichampt; Fanny Raguideau; Philippe Ricordeau; Pierre-Olivier Blotière; Jérémie Rudant; François Alla; Mahmoud Zureik
Journal:  BMJ       Date:  2016-05-10

9.  Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Authors:  Øjvind Lidegaard; Ellen Løkkegaard; Anne Louise Svendsen; Carsten Agger
Journal:  BMJ       Date:  2009-08-13

Review 10.  Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.

Authors:  Bernardine H Stegeman; Marcos de Bastos; Frits R Rosendaal; A van Hylckama Vlieg; Frans M Helmerhorst; Theo Stijnen; Olaf M Dekkers
Journal:  BMJ       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.